All things are born at the right time; share the same virtue with the son, and win together with the son.

--Inscription

Recently, TIANS Engineering Technology Group Co., Ltd. (hereinafter referred to as "TIANS Group") and CB Consultancy AG (hereinafter referred to as "CBC") reached an in-depth strategic cooperation agreement in the form of equity acquisition. CBC will serve as the conceptual design team for the general contracting business of TIANS's biomedical engineering and become the leading force for the overall solution of TIANS's biomedical engineering. At the same time, Mr. Bachofen, the founder of CBC, will serve as the Chief Technology Officer of TIANS Group's biomedicine, leading and promoting TIANS Group's rapid development in the EPC field of biomedical engineering with his rich industry experience.

CB Consultancy AG is a Swiss consulting company that provides professional design, construction management and industrial plant operations for global pharmaceutical companies. The company focuses on biopharmaceutical and high-end preparation projects. It has strong design capabilities in monoclonal antibodies, proteins, vaccines, and new crown vaccines. The main designers have more than 20 years of experience in pharmaceutical plant design, engineering planning and consulting. Experience. CBC's business covers Switzerland, Europe and Asia. So far, it has served many large international biopharmaceutical companies such as Johnson & Johnson, Roche, Novartis, and has been rooted in the Chinese market for more than ten years. It has also cooperated with Zhongsheng Group, BeiGene, Luye Pharmaceutical and other well-known pharmaceutical companies have long-term friendly cooperation, and are the world's leading conceptual design and consulting service company. Carry out plant planning, conceptual design, basic design, WHO pre-certification and other design consulting work in China.

Mr. Bachofen is an internationally renowned expert in biomedicine design and planning, the founder and chief designer of CB Consultancy AG, and the chief technology officer of Biomedicine of TIANS Group.

Mr. Bachofen has extensive experience in the planning and design of pharmaceutical plant facilities, GMP clean room and HVAC system design, pharmaceutical water system design, and quality management systems. As the project leader, he participated in a number of internationally renowned biomedical design projects, including the design of the Johnson & Johnson Pharmaceutical freeze-dried antibody production plant and the monoclonal antibody-xilin bottle packaging line design project, the Novartis Pharmaceutical R&D Park office building and the design of the laboratory building for R&D Project, BeiGene Suzhou pilot production workshop and Guangzhou commercial production workshop design project and Zhongsheng Group's new crown vaccine production workshop and many other projects.

Novartis Basel Park Project

TIANS Group is a well-known large-scale pharmaceutical, environmental protection, and metallurgical project construction general contracting service provider in China. It was founded in August 1998. Its main business includes engineering consulting and design, biomedical engineering general contracting, chemical medicine engineering general contracting, and Chinese Ten major business areas: general contracting of patent medicine engineering, general contracting of medical device engineering, general contracting of food and health engineering, general contracting of environmental protection technology and engineering, general contracting of metallurgical engineering, automation and information engineering, and continuous consumption equipment. In the course of more than 20 years of development, TIANS has served more than 200 well-known pharmaceutical companies, including more than 50 of the top 100 pharmaceutical companies, and participated in the construction of nearly 100 pharmaceutical factory facilities that meet the requirements of China's new GMP, FDA and EMA , Has become a representative case in the field of large-molecule biological drugs and highly active products, especially in the field of new biological agents such as monoclonal antibodies, vaccines, insulin, cell therapy, and gene therapy.

This strategic cooperation with CBC has greatly enhanced the engineering technology strength of TIANS Group in the field of biomedicine. Mr. Bachofen's rich experience in the field of biopharmaceutical engineering and international leading design ideas will help TIANS Group in the biomedical engineering A new chapter has begun in the EPC field. In the future, TIANS Group will also give full play to the high-quality design and engineering resources advantages of Mr. Christian and CBC, to provide customers with higher-quality EPC turnkey projects and help the rapid development of China biomedical industry.

All things are born at the right time; share the same virtue with the son, and win-win with the son.

--Inscription

Recently, TIANS Engineering Technology Group Co., Ltd. (hereinafter referred to as "TIANS Group") and CB Consultancy AG (hereinafter referred to as "CBC") reached an in-depth strategic cooperation agreement in the form of equity acquisition. CBC will serve as the conceptual design team for the general contracting business of Biomedical Engineering and become the leading force in the overall solution of Biomedical Engineering. At the same time, Mr. Christian Bachofen, the founder of CBC, will serve as the Chief Technology Officer of Biomedicine of TIANS Group. With his rich industry experience, he will lead and promote the rapid development of TIANS Group in the field of biomedical engineering EPC.

CB Consultancy AG is a Swiss consulting company providing professional design, construction project management and industrial plant operation for global pharmaceutical companies. The company focuses on biopharmaceutical and high-end preparation projects, and has strong design strength in projects such as monoclonal antibodies, proteins, vaccines and new crown vaccines, and the main designers have more than 20 years of experience in pharmaceutical plant design, engineering planning and consulting. Experience. CBC's business covers Switzerland, Europe and Asia. So far, it has served many large international biopharmaceutical companies such as Johnson & Johnson, Roche, Novartis, and has been rooted in the Chinese market for more than ten years. It has also cooperated with Zhongsheng Group, BeiGene, Luye Pharma and other well-known pharmaceutical companies have long-term friendly cooperation and are an international leading concept design and consulting service company. Carry out design consulting work such as plant area planning, conceptual design, basic design, and WHO pre-certification in China.

Mr. Christian Bachofen is an internationally renowned expert in biomedical design and planning, the founder and chief designer of CB Consultancy AG, and the chief technology officer of Biomedicine of TIANS Group.

Mr. Christian has extensive experience in the planning and design of pharmaceutical plant facilities, GMP clean room and HVAC system design, pharmaceutical water system design, and quality management systems. As the project leader, he has participated in a number of internationally renowned biopharmaceutical design projects, including Johnson & Johnson's freeze-dried antibody production plant and monoclonal antibody-vial dispensing line design project, Novartis Pharmaceuticals R&D Park office building and R&D laboratory building design Project, BeiGene Suzhou pilot production workshop and Guangzhou commercial production workshop design project and Zhongsheng Group's new crown vaccine production workshop and many other projects.

TIANS Group is a well-known general contracting service provider for large-scale pharmaceutical, environmental protection and metallurgical project construction in China. General contracting of patent medicine engineering, general contracting of medical device engineering, general contracting of food and health engineering, general contracting of environmental protection technology and engineering, general contracting of metallurgical engineering, automation information engineering, and continuous consumption equipment. In the course of more than 20 years of development, TIANS has served more than 200 well-known pharmaceutical companies, including more than 50 of the top 100 pharmaceutical companies, and participated in the construction of nearly 100 pharmaceutical factories that meet the requirements of China's new GMP, FDA and EMA. , has been in the field of macromolecular biological drugs and highly active products, especially in the field of new biological preparations such as monoclonal antibodies, vaccines, insulin, cell therapy, gene therapy, etc. There are industry-representative cases.

This strategic cooperation with CBC has greatly enhanced the engineering and technical strength of TIANS Group in the field of biomedicine. Mr. Christian's rich experience in the field of biopharmaceutical engineering and international leading design ideas will help TIANS Group in biomedical engineering. A new chapter begins in the EPC field. In the future, TIANS Group will also give full play to the advantages of high-quality design and engineering resources including Mr. Christian and CBC, provide customers with higher-quality EPC turnkey projects, and help the rapid development of China's biopharmaceutical industry.

On July 7, the 2021 (sixteenth) Qingdao International Water Conference was successfully concluded in Qingdao West Coast New District! As the most influential water industry exchange platform in the Asia-Pacific region, this International Water Conference attracted more than 100 universities and research institutes More than 300 industry authoritative experts and more than 1,500 industry companies gathered in Qingdao to discuss technological development countermeasures and explore new opportunities for industry development. Chen Ping, director, executive vice president, and chairman of the environmental protection division of TIANS Group, was invited to attend the Industrial Water Saving and Resource Utilization Forum and gave a special report on "New Technologies for Resource Utilization in the Pharmaceutical Industry".

Entering the first year of the "14th Five-Year Plan", the long-term goals of "being basically achieved the goal of a beautiful China" and "achieving new progress in the construction of ecological civilization" put forward new requirements in the field of water conservation and water treatment. In the high-salt wastewater reuse and zero-discharge theme forum in the high-water consumption industry, Chen Ping combined years of industry experience, from the reasons for the utilization of wastewater resources, the overall planning of pharmaceutical wastewater resources, nanofiltration membrane acid-base recovery technology, and miscellaneous salt separation. The five key resource utilization technologies and cases including purification technology were introduced in detail. In the first year of "carbon neutrality", the continuous use of water resources is an important area for achieving carbon peaks and carbon neutrality. Chen Ping pointed out that pollution control in the pharmaceutical industry is a pain point in the industry. To solve this pain point, it is necessary to stick to the direction of resource utilization. From the overall planning of the project, to the selection of the process route, to the realization of the treatment process, each link requires strong professional technology to support, in order to finally realize the water reuse and achieve the goal of building a green factory.

As a leader in environmental protection engineering T-EPC, TIANS Group has a systematic understanding of water treatment in many industrial fields such as environmental protection, medicine, metallurgy and other industrial fields, with deep technical background and project practice, and has mastered the current mature and advanced waste water and waste gas. Processing unit technology and energy-saving and emission-reduction technology, combining technology units reasonably according to customer needs, realize the recycling of industrial pollutants, and help customers build green factories.

During the conference, the National Separation Membrane Standardization Technical Committee held a special meeting to discuss the recent work of the Standards Committee and the 6 standards that have been approved, as the national standard "Test Method for Hydrophobic Performance of Porous Hydrophobic Membrane" (20202740-T-469) Editor, Chen Ping was invited to attend and offer suggestions on standard content.

On July 2, the QbD full life cycle seminar for biopharmaceutical production facilities sponsored by the School of Continuing Education of Shanghai Jiao Tong University was successfully held at Shanghai Jiao Tong University. Ding Zhijie, vice president and chief designer of TIANS Group, was invited to attend and gave a special training on "Engineering Design of Biological Products (Mab, Cell Therapy, Gene Therapy) and Facilities". Focusing on topics such as clean plant design and compliance management, nearly a hundred decision-makers related to R&D, technology, quality, and engineering from major pharmaceutical companies across the country gathered together to seek common development. After the training, they were awarded by Shanghai Jiaotong University. Certificate of completion.

Ding Zhijie combined his years of project design experience, from the characteristics and dosage forms (URS) of biological products (monoclonal antibodies, cell therapy and gene therapy drugs), the regulations that the project needs to comply with (GMP), and the prevention and control of cross-contamination (Risk). Assessment), the impact of the production process on the environment and prevention (EHS), the impact of the production process on the operators and prevention (EHS) and the consideration of biological safety in the design, the setting of the flow of people, logistics, waste flow, and the setting of the purification air conditioning system , Self-control and other five areas of focus have been carefully shared.

As a strategic development industry in my country, biopharmaceuticals have developed vigorously in recent years, and a large number of R&D projects have entered the stage of applying for clinical and applying for production. Monoclonal antibodies, double antibodies, tertiary antibodies and even polyclonal drugs, ADC drugs, CAR-T, CAR-NK and other drugs or therapies have become the fastest growing and most active fields. A group of industry experts including Guo Aijun, chief expert of the American Research Center of the University of International Business and Economics, Ni Jianhong, chief engineer of Shanghai Boehringer Ingelheim Pharmaceuticals, and Zheng Huailiang, vice president of IT of Cinda Biopharmaceutical Group Detailed reports were made on topics such as enterprise informatization construction.

As a leading domestic one-stop solution provider for biomedical engineering projects, TIANS Group has served many leading biopharmaceutical companies such as Junshi Biology, Heyuan Biology, Maiwei Biology, etc., and has many national standard drafters. A team of leading experts in the industry has participated in and led the construction of nearly 100 biopharmaceutical factory facilities that comply with China's new GMP and FDA requirements, and is in an industry leading position in the design and construction of biomedical laboratories.

On May 28th, the University EMBA Shanghai Study Tour and the opening ceremony of Class 2021 kicked off at the Junli Hongqiao Holiday Inn in Shanghai. A total of 22 students from Class 2020 and Class 2021 participated in the study tour. Zhang Xinqiao, director and vice president of the Group, delivered a speech at the opening ceremony. Yan Weiping, President of The University, and Chen Lu, President of the Management and Research Institute jointly attended the event.

A journey of a thousand miles begins

Zhang Xinqiao, director and vice president of the Group: "The Times is an organization of loving wisdom and seeking truth. A truly outstanding enterprise in the future will be an organization of continuous learning."Really good individuals in the future will also be those who will continue to improve themselves. Only learning can let us continue to grow up, only growth can hold up our life dream. The University EMBA is an exploration, an exploration dedicated to collision management knowledge, cultivating organizational leaders, enhancing self-worth, and promoting social progress; a process, a process of turning knowledge into assets, a process of learning through constant communication, an experience, an experience dedicated to creating a better learning environment for students, and becoming a lifelong aftertaste, a poor experience to practice. But learning is never immediate results, learning is a process of precipitation, such as bamboo shoots, do not see its long, but it is increasing. I hope you will have dreams in the next two years of EMBA study, work hard, follow the light, become light and emit light.

Group director and vice president Zhang Xinqiao delivered a speech at the opening ceremony

Xing Jiafeng, monitor of Class EMBA2020 of University: As the representative of Class 2020, Xing Jiafeng talked about the classroom learning experience of the past year. As society changes with each passing day, lifelong learning is imperative. We can't go far only on the existing knowledge. And to "endured hardships, to open the mountains, hardships, jade in cheng" to encourage everyone.

University EMBA2021 class monitor Xu Jifeng: male pass is really like iron, a hundred battles back to read again. We all from the group departments, division, work in the country at ordinary times, in the tense work, get together to study, although the time is short we will cherish, because experienced the test of work and social, we can know more clearly the significance of continuous learning to us. In the future, through the sharing of teachers and the communication and collision between students, we will take people's strengths to make up for our own weaknesses, learn in thinking, grow up in learning, constantly challenge new heights, and achieve a different self.

Learn from the wise man:

In the first lesson of the study tour, Mr.Ai Xuejiao, the founder of the famous crisis management expert, China crisis management cutting theory, 5 degree theory and crisis change theory, was specially invited to give lectures and share the course of "Public Opinion PR and Crisis Management" with the students.

Teacher Ai Xuejiao shared the course of "Public Opinion Public Relations and Crisis Management" with the students

In the Internet era where everyone is "we media", information dissemination becomes timely and fast, and the improper processing of negative information is easily evolved into a public opinion crisis, which will seriously affect the image of enterprises and individuals. Therefore, public opinion public relations and crisis management have become an important concern of enterprises today. Grasping the correct way of crisis management can turn resistance into help and turn the crisis into a turning point.

Curriculum, ai teacher with highly concentrated information, highly vivid case analysis, simple theory system, with his original crisis management methodology and the most effective crisis system theory and operation experience, share how the enterprise to prevent crisis, benefit, turn the crisis into opportunity, enhance the students' crisis consciousness, also improve the students crisis management ability.

Students actively share and communicate in class

Talk with the wise man about the achievement of extraordinary extracurricular expansion article:

The integration of knowledge and action is the core concept of study Tours. After knowledge enriches our brains, we have to go out and measure the world with our steps.

Duoyun Academy, enjoy the beauty of reading. On the morning of May 29th, all the students visited Duoyun Academy on the 52nd floor of the Shanghai center. A bookstore floating in the cloud. Let us stand on high ground, enjoy a different reading world and feel the beauty of different words. Reading in the bookstore is a way of life for modern people. Compared with the magnificent urban architecture and the competition of the Huangpu River, Duoyun Academy is more immersive and peaceful. Here, we can stay away from the hustle and bustle, seek inner peace, explore the unknown and explore the meaning.

Students explore the world of the book at Duoyun Academy

Enter the perfect world, feel the cultural and creative thinking. On the afternoon, we crossed the Huangpu River and visited the Perfect World Zhengqi (Shanghai) Multimedia Technology Co., Ltd. located in Puxi. Perfect World's business covers three major sectors: e-sports, games and film and television. Although it is different from our industry, we benefit a lot from their management model of pursuing essence, encouraging innovation, breaking boundaries and achieving integrated growth.

Students visit Perfect World Zhengqi Multimedia Technology Co., LTD

With the group photo in front of the Huangpu River, our two-day study tour in Shanghai also came to an end. In this study tour, the students become themselves through their efforts and thinking, and grow up in their dreams and practice. Tomorrow, the students will go to their respective jobs, although scattered throughout the world, but always all the way to chase the light, each other shine. The University EMBA, centered on growth, driven by lifelong learning, goes forward, love wisdom and seek truth, and born to the dream.

Modern University EMBA students take a group photo in front of the Huangpu River

List of Interchronological University Class EMBA 2021 students (ranked by last name):

Chen Xiaofei, Deputy director of Chen Ping Laboratory

Guo Lei, Deputy General manager of metallurgical Business Division, General manager of metallurgical Engineering Design Company

Jiang Xiaolin, Assistant President and Minister of Cooperation and Development Department

Li Zhijing, deputy general manager of the second Engineering Company, Chemical Medicine Division

Liu Dajun, general manager of the First Engineering Company, Environmental Protection Business Division

Miao Zhengxu mining control Center

Peng Xiaohui, Deputy General Manager of Automatic Control Business Division

Qin Yi, Deputy General Manager of Shanghai Business Division

Song Hongwei, General Manager of the Third Engineering Company of Chemical Engineering Division

Song Xiaohui, Vice president, general manager of Marketing Center, chairman of Food and Health Division

Wang Xiaoqing, deputy general manager of Clean Technology Company

Manager of Chemical Medicine Engineering Department II of Sichuan Automation Control Division

Wei Xuesong pharmaceutical engineering design company general manager assistant, the person in charge of the first room of process professional

Xu Jifeng, General Manager of the First Engineering Company of Metallurgical Business Division

Yang Runyu, Deputy General Manager of Shanghai Business Division

Project leader of Pharmaceutical Engineering Design Company, Yuliuxiang Chemical Medicine Department

Zhu Hao Project Manager of Project Manager Department of First Metallurgical Division